tiprankstipranks
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Ascendis Pharma (ASND) Technical Analysis

Compare
570 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Ascendis Pharma’s (ASND) Moving Averages Convergence Divergence (MACD) indicator is 6.20, suggesting Ascendis Pharma is a Sell.
Ascendis Pharma’s (ASND) 20-Day exponential moving average is 156.35, while Ascendis Pharma’s (ASND) share price is $161.04, making it a Buy.
Ascendis Pharma’s (ASND) 50-Day exponential moving average is 147.33, while Ascendis Pharma’s (ASND) share price is $161.04, making it a Buy.

Ascendis Pharma (ASND) Pivot Points

Mar 27, 2025, 10:10 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
162.24
163.80
165.89
167.45
169.54
171.10
173.19
Fibonacci
163.80
165.19
166.05
167.45
168.84
169.70
171.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascendis Pharma (ASND) Moving Averages

Mar 27, 2025, 10:10 AM
Period
Simple
Exponential
MA5
164.86Sell
163.63Sell
MA10
161.34Sell
161.18Sell
MA20
155.77Buy
156.35Buy
MA50
142.49Buy
147.33Buy
MA100
137.05Buy
141.47Buy
MA200
135.47Buy
138.30Buy
Ascendis Pharma’s (ASND) 10-Day exponential moving average is 161.18, while Ascendis Pharma’s (ASND) share price is $161.04, making it a Sell.
Ascendis Pharma’s (ASND) 100-Day exponential moving average is 141.47, while Ascendis Pharma’s (ASND) share price is $161.04, making it a Buy.
Ascendis Pharma’s (ASND) stock price is $161.04 and Ascendis Pharma’s (ASND) 50-day simple moving average is 142.49, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $161.04 and Ascendis Pharma’s (ASND) 100-day simple moving average is 137.05, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $161.04 and Ascendis Pharma’s (ASND) 200-day simple moving average is 135.47, creating a Buy signal.

Ascendis Pharma (ASND) Technical Indicators

Mar 27, 2025, 10:10 AM
Name
Value
Implied Action
RSI (14)
56.91
Neutral
STOCH (9,6)
81.25
Sell
STOCHRSI (14)
86.70
Sell
MACD (12,26)
6.20
Sell
ADX (14)
29.58
Neutral
Williams %R
-25.40
Buy
CCI (14)
76.82
Neutral
ATR (14)
6.49
-
Ultimate Oscillator
59.49
Neutral
ROC
3.32
Buy
Ascendis Pharma’s (ASND) Relative Strength Index (RSI) is 56.91, creating a Neutral signal.
Ascendis Pharma’s (ASND) Trend Strength Indicator (ADX) is 29.58, creating a Neutral signal.
Ascendis Pharma’s (ASND) Commodity Channel Index (CCI) is 76.82, creating a Neutral signal.
Ascendis Pharma’s (ASND) Price Rate of Change (ROC) is 3.32, creating a Buy signal.

FAQ

Is ASND a Buy, Hold, or Sell?
Based on ASND’s technical indicators, ASND is a Buy.
    What is ASND’s RSI (14)?
    ASND’s RSI (14) is 56.91, which suggests ASND is a Neutral.
      What is ASND’s MACD?
      ASND’s MACD is 6.20, which suggests ASND is a Sell.
        What is ASND’s 5-day moving average?
        ASND’s 5-day moving average is 164.86, which suggests ASND is a Sell.
          What is ASND’s 20-day moving average?
          ASND 20-day moving average is 155.77, which suggests ASND is a Buy.
            What is ASND’s 50-day moving average?
            ASND’s 50-day moving average is 142.49, which suggests ASND is a Buy.
              What is ASND’s 200-day moving average?
              ASND’s 200-day moving average is 135.47, which suggests ASND is a Buy.
                What is ASND’s Williams % R (14)?
                ASND’s Williams % R (14) is -25.40, which suggests ASND is a Buy.
                  What is ASND’s CCI (14)?
                  ASND’s CCI (14) is 76.82, which suggests ASND is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis